Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Idexx Laboratories Inc (IDXX)

In Vitro & In Vivo Diagnostic Substances

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

ONE IDEXX DRIVE
WESTBROOK, ME

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/21/1991

Market Cap

40,641,830,361

Shares Outstanding

83,050,000

Weighted SO

83,051,702

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

WAT --.--%

IQV --.--%

CRL --.--%

RVTY --.--%

MTD --.--%

A --.--%

TMO --.--%

ILMN --.--%

DHR --.--%

Beta

1.3200

Last Div

0.0000

Range

372.5-583.39

Chg

8.2700

Avg Vol

553298

Mkt Cap

40641830361

Exch

NASDAQ

Country

US

Phone

207 556 0300

DCF Diff

321.9179

DCF

172.3096

Div Yield

0.0000

P/S

10.7382

EV Multiple

35.8704

P/FV

25.8198

Div Yield %

0.0000

P/E

48.2503

PEG

4.3182

Payout

0.0000

Current Ratio

1.3155

Quick Ratio

0.9752

Cash Ratio

0.3596

DSO

58.6642

DIO

92.6602

Op Cycle

151.3244

DPO

28.6469

CCC

122.6775

Gross Margin

0.6045

Op Margin

0.2867

Pretax Margin

0.2806

Net Margin

0.2234

Eff Tax Rate

0.2038

ROA

0.2476

ROE

0.5703

ROCE

0.4721

NI/EBT

0.7962

EBT/EBIT

0.9788

EBIT/Rev

0.2867

Debt Ratio

0.2826

D/E

0.6106

LT Debt/Cap

0.2493

Total Debt/Cap

0.3791

Int Coverage

-110.0472

CF/Debt

1.0044

Equity Multi

2.1610

Rec Turnover

6.2218

Pay Turnover

12.7414

Inv Turnover

3.9391

FA Turnover

4.5727

Asset Turnover

1.1083

OCF/Share

11.7292

FCF/Share

10.1531

Cash/Share

4.8601

OCF/Sales

0.2561

FCF/OCF

0.8656

CF Coverage

1.0044

ST Coverage

2.2018

CapEx Coverage

7.4422

Div&CapEx Cov

7.4422

P/BV

25.8198

P/B

25.8198

P/S

10.7382

P/E

48.2503

P/FCF

48.4435

P/OCF

42.0993

P/CF

42.0993

PEG

4.3182

P/S

10.7382

EV Multiple

35.8704

P/FV

25.8198

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 22, 11:26 Here's a new way to consider value for stocks in the S&P 500 Benzinga Jan 17, 11:00 Beyond The Numbers: 6 Analysts Discuss IDEXX Laboratories Stock MarketWatch Jan 09, 09:13 Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024 Seeking Alpha Dec 09, 08:15 Wall Street Breakfast: What Moved Markets Benzinga Nov 03, 11:00 5 Analysts Have This to Say About IDEXX Laboratories Zacks Investment Research Nov 01, 22:00 Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics Benzinga Nov 01, 12:32 Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers Benzinga Nov 01, 12:32 Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers

Revenue Product Segmentation